Furthermore, the combination of glutaminase inhibitors with chemotherapy agents also increased sensitivity of cancer cells to chemotherapy in pancreatic cancer and ovarian cancer (59, 117, 118). The gene discussed is GLS; the disease is ovarian carcinoma.